Log In
BCIQ
Print this Print this
 

sirolimus (NPC-12)

  Manage Alerts
Collapse Summary General Information
Company Nobelpharma Co. Ltd.
DescriptionSirolimus
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase III
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat lymphangioleiomyomatosis (LAM)
Regulatory Designation Japan - Orphan Drug (Treat lymphangioleiomyomatosis (LAM))
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today